The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Role of Phenol-Soluble Modulins in Staphylococcus epidermidis Biofilm Formation and Infection of Indwelling Medical Devices
Abstract
Phenol-soluble modulins (PSMs) are amphipathic, alpha-helical peptides that are secreted by staphylococci in high amounts in a quorum-sensing-controlled fashion. Studies performed predominantly in Staphylococcus aureus showed that PSMs structure biofilms, which results in reduced biofilm mass, while it has also been reported that S. aureus PSMs stabilize biofilms due to amyloid formation. We here analyzed the roles of PSMs in in-vitro and in-vivo biofilms of Staphylococcus epidermidis, the leading cause of indwelling device-associated biofilm infection. We produced isogenic deletion mutants for every S. epidermidis psm locus and a sequential deletion mutant in which production of all PSMs was abolished. In-vitro analysis substantiated the role of all PSMs in biofilm structuring. PSM-dependent biofilm expansion was not observed, in accordance with our finding that no S. epidermidis PSM produced amyloids. In a mouse model of indwelling device-associated infection, the total psm deletion mutant had a significant defect in dissemination. Notably, the total psm mutant produced a significantly more substantial biofilm on the implanted catheter than the wild-type strain. Our study, which for the first time directly quantified the impact of PSMs on biofilm expansion on an implanted device, shows that the in-vivo biofilm infection phenotype in S. epidermidis is in accordance with the PSM biofilm structuring and detachment model, which has important implications for the potential therapeutic application of quorum-sensing blockers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Different from other targets, the production of PSMs is generated by the direct binding of AgrA to its promoter [94,95].”
From A Review of Biofilm Formation of Staphylococcus aureus and Its Regulation Mechanism (2022) · cites this paper as [95]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, R., Braughton, K. R., Kretschmer, D., Bach, T.-H. L., Queck, S. Y., Li, M., Kennedy, A. D., Dorward, D. W., Klebanoff, S. J., Peschel, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1656 · Cited by 1,046
Self-citationMack, D., Fischer, W., Krokotsch, A., Leopold, K., Hartmann, R., Egge, H., & Laufs, R. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.1.175-183.1996 · Cited by 885
Staphylococcus δ-toxin induces allergic skin disease by activating mast cells
Nakamura, Y., Oscherwitz, J., Cease, K. B., Chan, S. M., Muñoz-Planillo, R., Hasegawa, M., Villaruz, A. E., Cheung, G. Y. C., McGavin, M. J., Travers, J. B., et al. (2013) · Nature · doi:10.1038/nature12655 · Cited by 558
Self-citationNeutrophils in innate host defense against Staphylococcus aureus infections
Rigby, K. M., & DeLeo, F. R. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0295-3 · Cited by 400
Conrady, D. G., Brescia, C. C., Horii, K., Weiss, A. A., Hassett, D. J., & Herr, A. B. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807717105 · Cited by 216
Research works printed but not linked: 50
- Darouiche, 2001, Device-associated infections: a macroproblem that starts with microadherence, Clin. Infect. Dis., 33, 1567, 10.1086/323130 · DOI · Paper page
- von Eiff, 2005, Infections associated with medical devices: pathogenesis, management and prophylaxis, Drugs., 65, 179, 10.2165/00003495-200565020-00003 · DOI · Paper page
- Donlan, 2002, Biofilms: survival mechanisms of clinically relevant microorganisms, Clin. Microbiol. Rev., 15, 167, 10.1128/CMR.15.2.167-193.2002 · DOI · Paper page
- Otto, 2009, Staphylococcus epidermidis—the ‘accidental’ pathogen, Nat. Rev. Microbiol., 7, 555, 10.1038/nrmicro2182 · DOI · Paper page
- Zheng, 2018, Colonization of medical devices by staphylococci, Environ. Microbiol., 20, 3141, 10.1111/1462-2920.14129 · DOI · Paper page
- Kloos, 1975, Distribution and persistence of Staphylococcus and Micrococcus species and other aerobic bacteria on human skin, Appl. Microbiol., 30, 381, 10.1128/AM.30.3.381-395.1975 · DOI · Paper page
- Otto, 2008, Staphylococcal biofilms, Curr. Top. Microbiol. Immunol., 322, 207
- Hussain, 1997, A 140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces, Infect. Immun., 65, 519, 10.1128/IAI.65.2.519-524.1997 · DOI · Paper page
- Schaeffer, 2015, Accumulation-associated protein enhances Staphylococcus epidermidis biofilm formation under dynamic conditions and is required for infection in a rat catheter model, Infect. Immun., 83, 214, 10.1128/IAI.02177-14 · DOI
- Rupp, 1999, Characterization of the importance of polysaccharide intercellular adhesin/hemagglutinin of Staphylococcus epidermidis in the pathogenesis of biomaterial-based infection in a mouse foreign body infection model, Infect. Immun., 67, 2627, 10.1128/IAI.67.5.2627-2632.1999 · DOI · Paper page
- Rupp, 1999, Characterization of Staphylococcus epidermidis polysaccharide intercellular adhesin/hemagglutinin in the pathogenesis of intravascular catheter-associated infection in a rat model, Infect. Immun., 67, 2656, 10.1128/IAI.67.5.2656-2659.1999 · DOI · Paper page
- Decker, 2015, An 18 kDa scaffold protein is critical for Staphylococcus epidermidis biofilm formation, PLoS Pathog., 11, 10.1371/journal.ppat.1004735 · DOI
- Wang, 2018, Staphylococcus epidermidis small basic protein (Sbp) forms amyloid fibrils, consistent with its function as a scaffolding protein in biofilms, J. Biol. Chem., 293, 14296, 10.1074/jbc.RA118.002448 · DOI
- Rohde, 2007, Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections, Biomaterials., 28, 1711, 10.1016/j.biomaterials.2006.11.046 · DOI · Paper page
- Otto, 2013, Staphylococcal infections: mechanisms of biofilm maturation and detachment as critical determinants of pathogenicity, Annu. Rev. Med., 64, 175, 10.1146/annurev-med-042711-140023 · DOI · Paper page
- Boles, 2011, Staphylococcal biofilm disassembly, Trends Microbiol., 19, 449, 10.1016/j.tim.2011.06.004 · DOI · Paper page
- Loughran, 2014, Impact of individual extracellular proteases on Staphylococcus aureus biofilm formation in diverse clinical isolates and their isogenic sarA mutants, Microbiologyopen., 3, 897, 10.1002/mbo3.214 · DOI · Paper page
- Wang, 2011, Staphylococcus epidermidis surfactant peptides promote biofilm maturation and dissemination of biofilm-associated infection in mice, J. Clin. Invest., 121, 238, 10.1172/JCI42520 · DOI · Paper page
- Periasamy, 2012, How Staphylococcus aureus biofilms develop their characteristic structure, Proc. Natl. Acad. Sci. U. S. A., 109, 1281, 10.1073/pnas.1115006109 · DOI · Paper page
- Otto, 2014, Phenol-soluble modulins, Int. J. Med. Microbiol., 304, 164, 10.1016/j.ijmm.2013.11.019 · DOI · Paper page
- Dastgheyb, 2015, Role of phenol-soluble modulins in formation of Staphylococcus aureus biofilms in synovial fluid, Infect. Immun., 83, 2966, 10.1128/IAI.00394-15 · DOI
- Peschel, 2013, Phenol-soluble modulins and staphylococcal infection, Nat. Rev. Microbiol., 11, 667, 10.1038/nrmicro3110 · DOI · Paper page
- Cheung, 2014, Phenol-soluble modulins—critical determinants of staphylococcal virulence, FEMS Microbiol. Rev., 38, 698, 10.1111/1574-6976.12057 · DOI · Paper page
- Schwartz, 2012, Functional amyloids composed of phenol soluble modulins stabilize Staphylococcus aureus biofilms, PLoS Pathog., 8, 10.1371/journal.ppat.1002744 · DOI · Paper page
- Zheng, 2018, Do amyloid structures formed by Staphylococcus aureus phenol-soluble modulins have a biological function?, Int. J. Med. Microbiol., 308, 675, 10.1016/j.ijmm.2017.08.010 · DOI
- Cheung, 2010, Staphylococcus epidermidis strategies to avoid killing by human neutrophils, PLoS Pathog., 6, 10.1371/journal.ppat.1001133 · DOI · Paper page
- Mehlin, 1999, An inflammatory polypeptide complex from Staphylococcus epidermidis: isolation and characterization, J. Exp. Med., 189, 907, 10.1084/jem.189.6.907 · DOI · Paper page
- Yao, 2005, Genomewide analysis of gene expression in Staphylococcus epidermidis biofilms: insights into the pathophysiology of S. epidermidis biofilms and the role of phenol-soluble modulins in formation of biofilms, J. Infect. Dis., 191, 289, 10.1086/426945 · DOI · Paper page
- Mack, 1992, Parallel induction by glucose of adherence and a polysaccharide antigen specific for plastic-adherent Staphylococcus epidermidis: evidence for functional relation to intercellular adhesion, Infect. Immun., 60, 2048, 10.1128/IAI.60.5.2048-2057.1992 · DOI · Paper page
- Novick, 1993, Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule, EMBO J., 12, 3967, 10.1002/j.1460-2075.1993.tb06074.x · DOI · Paper page
- Queck, 2008, RNAIII-independent target gene control by the agr quorum-sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus, Mol. Cell, 32, 150, 10.1016/j.molcel.2008.08.005 · DOI · Paper page
- Chatterjee, 2013, Essential Staphylococcus aureus toxin export system, Nat. Med., 19, 364, 10.1038/nm.3047 · DOI · Paper page
- Somerville, 2002, In vitro serial passage of Staphylococcus aureus: changes in physiology, virulence factor production, and agr nucleotide sequence, J. Bacteriol., 184, 1430, 10.1128/JB.184.5.1430-1437.2002 · DOI · Paper page
- Villaruz, 2009, A point mutation in the agr locus rather than expression of the Panton-Valentine leukocidin caused previously reported phenotypes in Staphylococcus aureus pneumonia and gene regulation, J. Infect. Dis., 200, 724, 10.1086/604728 · DOI
- Vuong, 2000, Construction and characterization of an agr deletion mutant of Staphylococcus epidermidis, Infect. Immun., 68, 1048, 10.1128/IAI.68.3.1048-1053.2000 · DOI
- Yao, 2006, Characterization of the Staphylococcus epidermidis accessory-gene regulator response: quorum-sensing regulation of resistance to human innate host defense, J. Infect. Dis., 193, 841, 10.1086/500246 · DOI
- Malone, 2017, Approaches to biofilm-associated infections: the need for standardized and relevant biofilm methods for clinical applications, Expert Rev. Anti-Infect. Ther., 15, 147, 10.1080/14787210.2017.1262257 · DOI
- Kadurugamuwa, 2004, Noninvasive optical imaging method to evaluate postantibiotic effects on biofilm infection in vivo, Antimicrob. Agents Chemother., 48, 2283, 10.1128/AAC.48.6.2283-2287.2004 · DOI
- Vuong, 2008, Development of real-time in vivo imaging of device-related Staphylococcus epidermidis infection in mice and influence of animal immune status on susceptibility to infection, J. Infect. Dis., 198, 258, 10.1086/589307 · DOI
- Hall, 1992, Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies, Blood Rev., 6, 163, 10.1016/0268-960X(92)90028-O · DOI · Paper page
- Joo, 2012, Molecular basis of in vivo biofilm formation by bacterial pathogens, Chem. Biol., 19, 1503, 10.1016/j.chembiol.2012.10.022 · DOI · Paper page
- Le, 2014, Molecular determinants of staphylococcal biofilm dispersal and structuring, Front. Cell. Infect. Microbiol., 4, 167, 10.3389/fcimb.2014.00167 · DOI · Paper page
- Tayeb-Fligelman, 2017, The cytotoxic Staphylococcus aureus PSMalpha3 reveals a cross-alpha amyloid-like fibril, Science., 355, 831, 10.1126/science.aaf4901 · DOI · Paper page
- Dickey, 2017, Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance, Nat. Rev. Drug Discov., 16, 457, 10.1038/nrd.2017.23 · DOI · Paper page
- Le, 2015, Quorum-sensing regulation in staphylococci-an overview, Front. Microbiol., 6, 1174, 10.3389/fmicb.2015.01174 · DOI · Paper page
- Kong, 2006, Staphylococcus quorum sensing in biofilm formation and infection, Int. J. Med. Microbiol., 296, 133, 10.1016/j.ijmm.2006.01.042 · DOI · Paper page
- Vuong, 2003, Quorum-sensing control of biofilm factors in Staphylococcus epidermidis, J. Infect. Dis., 188, 706, 10.1086/377239 · DOI · Paper page
- Bae, 2006, Allelic replacement in Staphylococcus aureus with inducible counter-selection, Plasmid., 55, 58, 10.1016/j.plasmid.2005.05.005 · DOI · Paper page
- Joo, 2014, The isolation and analysis of phenol-soluble modulins of Staphylococcus epidermidis, Methods Mol. Biol., 1106, 93, 10.1007/978-1-62703-736-5_7 · DOI
- Piewngam, 2018, Pathogen elimination by probiotic Bacillus via signalling interference, Nature., 562, 532, 10.1038/s41586-018-0616-y · DOI · Paper page
Cited by
Staphylococcal Biofilm Development: Structure, Regulation, and Treatment Strategies
Schilcher, K., & Horswill, A. R. (2020) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00026-19 · Cited by 706
A Review of Biofilm Formation of Staphylococcus aureus and Its Regulation Mechanism
Peng, Q., Tang, X., Dong, W., Sun, N., & Yuan, W. (2022) · Antibiotics · doi:10.3390/antibiotics12010012 · Cited by 440
The Skin Microbiota: Balancing Risk and Reward
Flowers, L., & Grice, E. A. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.06.017 · Cited by 276
Metadata
- Authors
- Le, K. Y., Villaruz, A. E., Zheng, Y., He, L., Fisher, E. L., Nguyen, T. H., Ho, T. V., Yeh, A. J., Joo, H.-S., Cheung, G. Y. C., & Otto, M.
- Venue
- Journal of Molecular Biology
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 431
- Issue
- 16
- Pages
- 3015-3027
- ISSN
- 0022-2836
- Cited by
- 77
- References
- 5
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- National Institute of Allergy and Infectious Diseases (1 ZIA AI000904)
- National Institutes of Health
- National Natural Science Foundation of China (81501804)
- General Program of Shanghai Municipal Commission of Health and Family Planning (20154Y0014)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.